Literature DB >> 950590

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

R J Sawchuk, D E Zaske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 950590     DOI： 10.1007/bf01086153

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  11 in total

1.  Dose of gentamicin in patients with normal renal function and renal impairment.

Authors:  J C Gingell; P M Waterworth
Journal:  Br Med J       Date:  1968-04-06

2.  Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae.

Authors:  M E Lund; D J Blazevic; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

3.  The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.

Authors:  D Kaye; M E Levison; E D Labovitz
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

4.  Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration.

Authors:  J W Paisley; A L Smith; D H Smith
Journal:  Am J Dis Child       Date:  1973-10

5.  Correlation of serum creatinine concentration and gentamicin half-life.

Authors:  R E Cutler; A M Gyselynck; W P Fleet; A W Forrey
Journal:  JAMA       Date:  1972-02-21       Impact factor: 56.272

6.  Pharmacokinetics of gentamicin: distribution and plasma and renal clearance.

Authors:  A M Gyselynck; A Forrey; R Cutler
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Gentamicin therapy in renal failure: a nomogram for dosage.

Authors:  R A Chan; E J Benner; P D Hoeprich
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

8.  Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration.

Authors:  M C McHenry; T L Gavan; R W Gifford; N A Geurkink; R A Van Ommen; M A Town; J G Wagner
Journal:  Ann Intern Med       Date:  1971-02       Impact factor: 25.391

9.  Prescribing aids for gentamicin.

Authors:  G E Mawer; R Ahmad; S M Dobbs; J G McGough; S B Lucas; J A Tooth
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

10.  Predictability of blood levels of gentamicin in man.

Authors:  M Barza; R B Brown; D Shen; M Gibaldi; L Weinstein
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226
View more
  96 in total

1.  Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.

Authors:  Toshimi Kimura; Keisuke Sunakawa; Nobuo Matsuura; Hiroaki Kubo; Shigehiko Shimada; Kazuo Yago
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Changes in gentamicin pharmacokinetic profiles induced by mechanical ventilation.

Authors:  C Triginer; I Izquierdo; R Fernández; J Torrent; S Benito; A Net; F Jane
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.

Authors:  K A Rodvold; J A Everett; R D Pryka; D M Kraus
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

4.  Optimizing the initial amikacin dosage in adults.

Authors:  Bryan P White; Ben Lomaestro; Manjunath P Pai
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

Review 5.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

6.  Gentamicin volume of distribution: non-compartmental determination for administration by intravenous infusion.

Authors:  C Cárcamo; L Castillo; A Gonzalez; M Ramos; J Ilić
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

7.  Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.

Authors:  Calvin L Miller; S Alexander Winans; John J Veillette; Steven C Forland
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 8.  Once-daily aminoglycoside administration: new strategies for an old drug.

Authors:  J M Kovarik; I M Hoepelman; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

Review 9.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.